The vast majority of glomus tumors are benign. Less than 2% of all glomus tumors are malignant, making cancerous versions extremely rare. Most people diagnosed with a glomus tumor have a small, painful but harmless growth that can be cured with surgery.
That said, the word “glomus tumor” can cause confusion because it’s used for two completely different things in medicine. Understanding what type you’re dealing with, where it is, and what features it has all matter for determining risk.
What a Glomus Tumor Actually Is
Glomus tumors grow from glomus bodies, tiny structures embedded in your skin that help regulate blood flow and temperature. These structures are densely packed in your fingertips, especially under the nails, which is why glomus tumors show up there most often. In a study of 138 cases, 42% were on the digits, with other common spots including the hands, arms, and legs.
One important distinction: “glomus tumor” sometimes gets mixed up with “glomus jugulare tumor,” which is actually a paraganglioma, a different type of tumor that forms from nerve-related cells near the skull base or neck. These are unrelated conditions despite the overlapping name. If your doctor mentioned a glomus jugulare or carotid body tumor, that’s a paraganglioma and has its own set of risks and treatments.
The Classic Symptoms
Glomus tumors, particularly those under a fingernail, produce a recognizable pattern: severe pain at a specific point, tenderness when pressed, and heightened sensitivity to cold. The pain can be intense and out of proportion to the size of the growth, which is often smaller than a centimeter. Many people go years before getting a correct diagnosis because the tumor is so small it doesn’t show up easily on examination.
When a Glomus Tumor Is Cancerous
A malignant glomus tumor (sometimes called glomangiosarcoma) is one of the rarest soft tissue cancers. These tumors tend to look different under a microscope: they grow into surrounding tissue in an infiltrative pattern, have high numbers of dividing cells, and often contain areas of dead tissue. Pathologists typically identify them by finding a recognizable benign glomus tumor component sitting next to tissue that looks like a sarcoma.
Location plays a significant role in risk. Glomus tumors in the fingers and superficial skin are overwhelmingly benign. Deep-seated tumors in organs like the stomach, lungs, liver, or intestines carry a much higher chance of being malignant. In one institutional review, a third of glomus tumors found in deep visceral locations turned out to be malignant, compared to a tiny fraction of those in the fingers or extremities.
Size and depth also raise suspicion. Tumors that are large, located deep in the body, or show infiltrative growth patterns are flagged for closer examination. Pathologists use specific criteria to sort these into three categories: clearly benign, malignant, or “uncertain malignant potential” for tumors that have some worrisome features but don’t meet the full threshold for a cancer diagnosis.
Symplastic Glomus Tumors: Scary Looking but Safe
Some glomus tumors have cells that look abnormal under a microscope, with enlarged, irregular nuclei that can alarm a pathologist at first glance. These are called symplastic glomus tumors. Despite their unusual appearance, they behave like benign tumors. In a landmark analysis of 52 atypical and malignant glomus tumors, not a single symplastic case spread to other parts of the body. If your pathology report mentions “symplastic” features but no other concerning signs, the prognosis is excellent.
What Happens if It Is Malignant
Malignant glomus tumors are considered low-grade sarcomas that rarely spread. They tend to be locally aggressive, meaning they can grow back in the same area after removal, but distant metastasis is uncommon. When metastasis does happen, however, outcomes are poor. In a review of cases with spread to multiple organs, six of eight patients died within three years. The average time between surgery and the appearance of widespread disease was about four years.
This creates a somewhat paradoxical picture: the cancer itself is low grade and usually manageable, but the small subset of cases that do metastasize tend to be fatal. This is why follow-up monitoring matters for anyone diagnosed with a malignant variant.
Treatment and Recurrence
For benign glomus tumors, complete surgical removal is the standard treatment and typically curative. Once the tumor is fully excised, most people experience immediate relief from pain. Recurrence rates in the published literature range widely, from 4% to 50%, largely depending on how completely the tumor was removed and what surgical approach was used. True recurrence is relatively rare when the entire tumor is taken out cleanly.
For malignant glomus tumors, surgery remains the primary treatment, but wider margins and longer follow-up are necessary given the potential for local regrowth or late metastasis.
Multiple Glomus Tumors and Genetics
Most glomus tumors appear as a single growth with no family connection. But some people develop multiple glomus tumors, a condition called glomuvenous malformations. This runs in families and is linked to inherited mutations in the glomulin gene on chromosome 1. The pattern follows what’s known as a “two-hit” model: you inherit one faulty copy of the gene, and a second mutation occurs in a specific tissue, triggering tumor formation at that site.
Having multiple glomus tumors does not mean they are cancerous. Glomuvenous malformations are benign. They can be painful and cosmetically bothersome, but malignant transformation in this setting is exceedingly rare.